Cart
sales@molnova.com
Tyrosinase-IN-16
CAS No. 126651-85-2
Tyrosinase-IN-16( —— )
Catalog No. M36097 CAS No. 126651-85-2
Tyrosinase-IN-16 inhibited tyrosinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 42 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 89 | In Stock |
|
| 200MG | 129 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrosinase-IN-16
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrosinase-IN-16 inhibited tyrosinase.
-
DescriptionTyrosinase-IN-16 (compound 19a) is a tyrosine kinase (Tyrosinase) inhibitor with Ki=470 nM. Tyrosinase-IN-16 is cytotoxic to B16F10 cells, with >90% inhibition at 20 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number126651-85-2
-
Formula Weight256.12
-
Molecular FormulaC8H6BrN3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESSC1=NN=C(N1)C1=CC=CC(Br)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Choi J, et al. Ensemble-Based Virtual Screening Led to the Discovery of New Classes of Potent Tyrosinase Inhibitors. J Chem Inf Model. 2016 Feb 22;56(2):354-67.?
molnova catalog
related products
-
BTK inhibitor 17
BTK inhibitor 17 is a potent irreversible BTK inhibitor (IC50 = 2.1 nM). BTK inhibitor 17 can be used in rheumatoid arthritis studies.
-
PCI-29732
A selective and irreversible Btk inhibitor with biochemical Ki of 8.2 nM.
-
Larotinib
Larotinib is an orally active, potent, and broad-spectrum tyrosine kinase inhibitor (TKI) with an IC50 of 0.6 nM for EGFR.
